This book offers an extensive examination of the impact of micro- and nanotechnology on vaccine development, highlighting the significant advancements made possible in research. It also sheds light on the obstacles faced by immunologists as they strive to push the boundaries of progress.

Version 1:
The utilization of MNT enables the production of particles that leverage the innate capability of the human immune system to detect small particles like viruses and toxins. When coupled with precise protective epitope design, this facilitates the creation of immunogenic particles that trigger a response against the targeted pathogen. Given the finely tuned response of the human immune system to small particles, it is not surprising that numerous leading adjuvants and vaccine delivery systems currently being explored are nanoparticle-based.

See also :